[go: up one dir, main page]

BR9808878A - Imunização contra moléculas endógenas - Google Patents

Imunização contra moléculas endógenas

Info

Publication number
BR9808878A
BR9808878A BR9808878-5A BR9808878A BR9808878A BR 9808878 A BR9808878 A BR 9808878A BR 9808878 A BR9808878 A BR 9808878A BR 9808878 A BR9808878 A BR 9808878A
Authority
BR
Brazil
Prior art keywords
endogenous molecules
immunization against
against endogenous
immune response
molecules
Prior art date
Application number
BR9808878-5A
Other languages
English (en)
Inventor
Richard Harland
John G Manns
Stephen D Acres
Original Assignee
Biostar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biostar Inc filed Critical Biostar Inc
Publication of BR9808878A publication Critical patent/BR9808878A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"IMUNIZAçãO CONTRA MOLéCULAS ENDóGENAS" é descrito um método para imunoneutralização de moléculas endógenas em indivíduos mamíferos, em que um imunógeno é administrado via injeção na orelha. O método é utilizado para desencadear uma resposta imune uniforme e eficaz para bloquear ou suprimir a atividade de um hormónio endógeno num indivíduo vacinado, ou para atingir uma célula infectada para uma resposta imune.
BR9808878-5A 1997-02-05 1998-02-04 Imunização contra moléculas endógenas BR9808878A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3688397P 1997-02-05 1997-02-05
PCT/CA1998/000059 WO1998034639A1 (en) 1997-02-05 1998-02-04 Immunization against endogenous molecules

Publications (1)

Publication Number Publication Date
BR9808878A true BR9808878A (pt) 2000-07-11

Family

ID=21891195

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9808878-5A BR9808878A (pt) 1997-02-05 1998-02-04 Imunização contra moléculas endógenas

Country Status (6)

Country Link
US (1) US20010014330A1 (pt)
EP (1) EP0981367A1 (pt)
AU (1) AU746643B2 (pt)
BR (1) BR9808878A (pt)
CA (1) CA2279826A1 (pt)
WO (1) WO1998034639A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0418317A (pt) * 2003-12-31 2007-05-02 Schering Plough Ltd vacina de aumento de crescimento à base de epitopo de neutralização
CA2594276A1 (en) * 2004-12-30 2006-07-13 Schering-Plough Ltd. Neutralizing epitope-based growth enhancing vaccine
KR20210119231A (ko) * 2020-03-24 2021-10-05 주식회사 바이오앱 동물의 중성화용 재조합 단백질 및 이를 포함하는 백신 조성물
KR102477054B1 (ko) * 2020-03-24 2022-12-14 주식회사 바이오앱 웅취 제거용 재조합 단백질 및 이를 포함하는 백신 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2690839B1 (fr) * 1992-05-06 1996-07-12 Rhone Merieux Ensemble de vaccination contre l'interotoxemie du lapin et vaccin conditionne pour etre utilise dans cet ensemble.

Also Published As

Publication number Publication date
AU746643B2 (en) 2002-05-02
WO1998034639A1 (en) 1998-08-13
US20010014330A1 (en) 2001-08-16
EP0981367A1 (en) 2000-03-01
CA2279826A1 (en) 1998-08-13
AU5849798A (en) 1998-08-26

Similar Documents

Publication Publication Date Title
ATE228373T1 (de) Unterdrückung von autoimmunkrankheiten durch antigene in wartestellung
DK0920322T3 (da) Anvendelser af modificeret autologt blod til behandling af autoimmunitetssygdomme
AU3040995A (en) Treatment of autoimmune diseases by oral administration of autoantigens
DE69030880D1 (de) Zusammensetzung zur Stimulierung des Immunsystems
FI920026A0 (fi) Farmaceutisk komposition anvaendbar som avmagringsmedicin.
CY1107571T1 (el) Αυξητικος παραγοντας νευρων ως βοηθητικη ουσια εμβολιου
DK1011653T3 (da) Anvendelse af xanthophyller i medikamenter til forbedring af varigheden af muskelfunktion eller behandling af muskelforstyrrelser eller -lidelser
AU4951196A (en) Vaccines for plague
BR9814473A (pt) Imunógenos anti-retrovirais, preparação e uso
EP0863913A4 (en) METHOD FOR RECOVERING THE DENSITY OF ANTIGENS ON ANTIGENT PRESENTING CELLS
DK0482089T3 (da) Fremgangsmåder til behandling af autoimmun uveoretnitis i mennesker
TR200100948T2 (tr) Cinsel yoldan bulaşan hastalıklara karşı aşı
DE69133077D1 (de) Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung
BR9808878A (pt) Imunização contra moléculas endógenas
NO962655D0 (no) Deutrerte virkestoffer i transdermal applikasjon
FI875015A0 (fi) Vaccin mot juverinflammation.
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
ATE258799T1 (de) Verwendung einer chemisch stabilisierten chloritlösung zur inhibition der antigenspezifischen immunantwort
FI932759A0 (fi) Anvaendningen av IL-4 foer oekning av pao vacciners immunogener verkande immunreaktioner
DE69429521D1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
DK1039931T3 (da) Multivalente rekombinante antistoffer til at behandle HRV infektioner
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
DK0929315T3 (da) Krydsbeskyttende equine herpesviruspræparater, deres fremstilling og anvendelse
BR9814556A (pt) Cepas isoladas de staphylococcus aureus e vacinas fabricadas a partir das mesmas
Monjour et al. Exploitation of parasite derived antigen in therapeutic success of human cutaneous leishmaniasis in Brazil

Legal Events

Date Code Title Description
PCP Transfer pending
PCR Transfer refused
B25A Requested transfer of rights approved

Owner name: METAMORPHIX INTERNATIONAL, INC. (US)

Free format text: TRANSFERIDO DE: BIOSTAR INC.

B25G Requested change of headquarter approved

Owner name: METAMORPHIX INTERNATIONAL, INC. (US)

Free format text: ALTERADA A SEDE DO TITULAR CONFORME REQUERIDO NA PETICAO NO 015309/RJ DE 22/03/2004.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1889 DE 20/03/2007.